GLUE Next Earnings Date image   This GLUE next earnings date page last updated 3/12/2026

GLUE Next Earnings Date Notes

— Monte Rosa Therapeutics (NASDAQ: GLUE) is a clinical-stage biotechnology company focused on developing small-molecule protein degraders, leveraging its proprietary QuEENTM (Quantitative & Engineered Elimination of Neoplastic Targets) platform. The company aims to target disease-causing proteins traditionally considered ȁcundruggable,ȁd with a primary emphasis on oncology & autoimmune conditions. For investors tracking GLUE's progress, key business metrics to monitor include the advancement of its clinical pipeline—especially lead candidates like MRT-2359 for solid tumors—and updates on new clinical trial initiations or data readouts. Other crucial factors are cash runway (including reported cash, cash equivalents & marketable securities), R&D expenses (reflecting clinical activity), and strategic partnerships or collaborations. Listening for management commentary on trial enrollment, efficacy/safety data, and regulatory milestones during the earnings call can offer additional insight into long-term execution & competitive positioning. As a pre-revenue biotech, Monte Rosa's future success will hinge on clinical trial progress, capital efficiency, & pipeline expansion, making updates on these fronts especially relevant for long-term investors. The next projected earnings date for GLUE is 3/23/2026 7:00 am (stay tuned for a confirmed earnings date once announced).
GLUE Next Earnings Date:3/23/2026
7:00 AM
(Projected earnings date)
Earnings Period:Q4 2025
Earnings Estimate:-0.380/share
Revenue Estimate:0.01B
Prior Q4 Earnings:0.230/share
Prior Q4 Revenue:0.06B
GLUE Listed On:NASDAQ
Comparative Importance of GLUE Next Earnings Date to the Market:

Next earnings date relative importance comparison
Next earnings date indicator GLUE

Also see: GLUE Earnings History
PeriodEarnings DateEarnings
Q3 202511/6/2025-0.330
Q2 20258/7/2025-0.150
Q1 20255/8/20250.570
Q4 20243/20/20250.230
Q3 202411/7/2024-0.290

Next Earnings Date Calendar:

Sleep Number (SNBR): 3/12/2026 6:00 AM
Rapid Micro Biosystems (RPID): 3/12/2026 6:00 AM
Urban One (UONEK): 3/12/2026 6:00 AM
Urban One (UONE): 3/12/2026 6:00 AM
GPGI (GPGI): 3/12/2026 6:05 AM
Vivid Seats (SEAT): 3/12/2026 6:30 AM
Build-A-Bear Workshop (BBW): 3/12/2026 6:45 AM
Dollar Gen (DG): 3/12/2026 6:50 AM
Dick's Sporting Goods (DKS): 3/12/2026 7:00 AM
Acuren (TIC): 3/12/2026 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Stoneridge (SRI): 3/11/2026 8:05 PM
KLX Energy Services Hldgs (KLXE): 3/11/2026 After close
Culp (CULP): 3/11/2026 After close
Ocean Power Techs (OPTT): 3/11/2026 After close
Alpha Pro Tech (APT): 3/11/2026 After close
Montauk Renewables (MNTK): 3/11/2026 After close
TechTarget (TTGT): 3/11/2026 After close
Velocity Financial (VEL): 3/11/2026 After close
UiPath (PATH): 3/11/2026 After close
Foghorn Therapeutics (FHTX): 3/11/2026 After close

More from the Earnings History archive
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree GLUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Monte Rosa Therapeutics (GLUE) is categorized under the Healthcare sector; to help you further research next earnings dates across stocks, below are some other companies in the same sector:

GLXY Next Earnings Date
GLYC Next Earnings Date
GMED Next Earnings Date
GMTX Next Earnings Date
GNCA Next Earnings Date
GNLX Next Earnings Date
GNPX Next Earnings Date
GOSS Next Earnings Date

GLUE Next Earnings Date FAQ

When is the GLUE next earnings date?
I am following Monte Rosa Therapeutics, under stock symbol GLUE, and I would like to know when is their next earnings date expected to be?

✔️Accepted answer: The next projected earnings date for GLUE is 3/23/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

  Suggested answer: Are you looking to know which fiscal year and quarter will be reported at the next GLUE earnings date? If so, it will be Q4 2025.

  Suggested answer: The GLUE next earnings report will be compared against the prior year Q4 earnings of 0.230/share on 0.06B of revenue.


How much is GLUE expected to earn at the next report?
When Monte Rosa Therapeutics has their next earnings report, what are people expecting as far as their earnings?

✔️Accepted answer: Based on the data we get, analysts are looking for -0.380/share out of GLUE at next report with top line of 0.01B.


On this page we presented the GLUE Next Earnings Date information for Monte Rosa Therapeutics along with recent past earnings dates. For Q3 of 2025, GLUE reported earnings of -0.330/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, GLUE reported earnings of -0.150/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, GLUE reported earnings of 0.570/share, with the earnings report taking place on 5/8/2025. For Q4 of 2024, GLUE reported earnings of 0.230/share, with the earnings report taking place on 3/20/2025. For Q3 of 2024, GLUE reported earnings of -0.290/share, with the earnings report taking place on 11/7/2024. Based on these past earnings dates, the projected next earnings date for GLUE is 3/23/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Monte Rosa Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Monte Rosa Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Monte Rosa Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next GLUE earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up GLUE's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the GLUE next earnings date.

Also recommended: CPOP market cap history, DWTR Options Chain, Funds Holding TDTH.

 

GLUE Next Earnings Date | www.NextEarningsDate.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.